Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07362225
Recruiting
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Not applicable · United States · 2 sites
Registry update: 23 Jan 2026
NCT07007312
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Australia, Belgium, Canada, Czechia, Germany, Spain, France, United Kingdom, Greece, Hungary, Italy, South Korea, Philippines, Poland, Portugal, Taiwan, United States · 167 sites
Registry update: 13 Oct 2026
NCT07354399
Recruiting
Resistance Training Added to Aerobic Interval Training to Improve Aerobic Capacity and Muscle Mass in Women With Coronary Artery Disease
Not applicable · Slovenia · 1 site
Registry update: 21 Jan 2026
NCT07133633
Recruiting
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · Brazil, Canada, Chile, China, Colombia, Germany, United Kingdom, South Korea, Netherlands, Poland, Taiwan, Ukraine, United States · 107 sites
Registry update: 23 Oct 2026
NCT07361107
Recruiting
Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)
Phase 1 · United States · 1 site
Registry update: 22 Jan 2026
NCT07313657
Recruiting
Improving Care and Mental Well-Being for Adults With Heart Failure
Not applicable · Canada · 9 sites
Registry update: 17 Feb 2026
NCT07097506
Recruiting
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
Phase 2 · United States · 1 site
Registry update: 15 Jul 2026
NCT07060950
Recruiting
Analysis of Circulating Tumor Markers in Blood - ALCINA 5
Not applicable · France · 1 site
Registry update: 6 Nov 2026
NCT06532747
Recruiting
Redefining BMI: The Body, Mind, and Inflammation Trial
Not applicable · United States · 1 site
Registry update: 6 May 2026
NCT07129993
Recruiting
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2/3 · Austria, China, Germany, France, Italy, Japan, United States · 95 sites
Registry update: 20 Aug 2026
NCT07039162
Recruiting
Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 · Taiwan · 8 sites
Registry update: 27 Feb 2026
NCT07184281
Recruiting
Effectiveness of School-Based Time-Restricted Eating for the Prevention and Control of Obesity in Children
Not applicable · China · 2 sites
Registry update: 30 Sept 2025
NCT07259343
Recruiting
Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric Population
Not applicable · Mexico · 1 site
Registry update: 2 Dec 2025
NCT06441331
Recruiting
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Phase 1 · Spain, France, Italy, United States · 10 sites
Registry update: 27 Oct 2026
NCT07205315
Recruiting
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Early phase 1 · China · 2 sites
Registry update: 20 Jul 2026
NCT06868927
Recruiting
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
Not applicable · Italy · 1 site
Registry update: 17 Mar 2026
NCT07255131
Recruiting
The Effectiveness and Efficacy of an Online Cognitive Behavioral Psychotherapeutic Program
Not applicable · Greece · 1 site
Registry update: 27 Jan 2026
NCT07046078
Recruiting
Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
Phase 2 · United States · 1 site
Registry update: 20 Jul 2026
NCT07052370
Recruiting
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
Phase 1 · United States · 1 site
Registry update: 2 Jun 2026
NCT07185256
Recruiting
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Phase 1/2 · United States · 5 sites
Registry update: 24 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.